Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 1 | 4 | 2021 | 196 | 1.360 |
Why?
|
Zebrafish | 25 | 2021 | 2994 | 1.040 |
Why?
|
Neuroblastoma | 5 | 2018 | 1226 | 0.660 |
Why?
|
Thiophenes | 2 | 2021 | 588 | 0.600 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1142 | 0.520 |
Why?
|
Sulfonamides | 2 | 2021 | 1938 | 0.420 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.420 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2011 | 191 | 0.370 |
Why?
|
Pyrimidines | 2 | 2021 | 2942 | 0.360 |
Why?
|
Zebrafish Proteins | 8 | 2018 | 1005 | 0.360 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1692 | 0.340 |
Why?
|
Neural Stem Cells | 1 | 2016 | 851 | 0.330 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 664 | 0.330 |
Why?
|
Embryo, Nonmammalian | 7 | 2018 | 895 | 0.330 |
Why?
|
Neoplasm Metastasis | 4 | 2017 | 4851 | 0.290 |
Why?
|
Melanoma | 3 | 2021 | 5510 | 0.280 |
Why?
|
Drug Synergism | 2 | 2021 | 1792 | 0.270 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18029 | 0.250 |
Why?
|
Gene Expression | 2 | 2016 | 7799 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2016 | 2942 | 0.220 |
Why?
|
Neoplasm Transplantation | 4 | 2018 | 2085 | 0.210 |
Why?
|
Signal Transduction | 8 | 2017 | 23403 | 0.180 |
Why?
|
Neutrophils | 1 | 2012 | 3719 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2214 | 0.170 |
Why?
|
Cell Survival | 3 | 2021 | 5882 | 0.160 |
Why?
|
Cell Proliferation | 6 | 2021 | 10481 | 0.140 |
Why?
|
Embryonic Development | 3 | 2012 | 711 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 480 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 489 | 0.140 |
Why?
|
Animals, Genetically Modified | 6 | 2017 | 1549 | 0.140 |
Why?
|
Cell Line, Tumor | 8 | 2021 | 16689 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 234 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 987 | 0.130 |
Why?
|
Animals | 26 | 2021 | 168757 | 0.130 |
Why?
|
Cell Tracking | 1 | 2016 | 145 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1341 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1434 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 379 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 190 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 407 | 0.120 |
Why?
|
Sirolimus | 1 | 2021 | 1564 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8428 | 0.110 |
Why?
|
Dioxygenases | 1 | 2014 | 316 | 0.110 |
Why?
|
Beclomethasone | 1 | 2012 | 38 | 0.110 |
Why?
|
Cell Movement | 4 | 2017 | 5217 | 0.110 |
Why?
|
Phosphorylase Kinase | 1 | 2011 | 10 | 0.110 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 79 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1265 | 0.100 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2011 | 62 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2018 | 6314 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2011 | 203 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2016 | 547 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2017 | 1526 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2017 | 1741 | 0.090 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 2382 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2018 | 3023 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1519 | 0.080 |
Why?
|
Gene Amplification | 3 | 2018 | 1063 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2014 | 2007 | 0.080 |
Why?
|
Carcinogens | 1 | 2011 | 466 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2948 | 0.080 |
Why?
|
Gastrula | 1 | 2008 | 84 | 0.080 |
Why?
|
Myeloid Cells | 1 | 2012 | 810 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 569 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9648 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 981 | 0.070 |
Why?
|
Pyrroles | 1 | 2012 | 1146 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2455 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2014 | 1352 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7722 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2915 | 0.060 |
Why?
|
Multigene Family | 2 | 2006 | 1102 | 0.060 |
Why?
|
Molecular Targeted Therapy | 2 | 2014 | 2727 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1839 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 5021 | 0.060 |
Why?
|
Gene Expression Profiling | 4 | 2017 | 9438 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2012 | 3479 | 0.050 |
Why?
|
Hyperplasia | 2 | 2017 | 1185 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2038 | 0.050 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 2635 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1285 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12208 | 0.050 |
Why?
|
Mice | 7 | 2018 | 81183 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10180 | 0.050 |
Why?
|
Mice, Nude | 2 | 2018 | 3689 | 0.040 |
Why?
|
Humans | 18 | 2021 | 744343 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3617 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3507 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2013 | 20822 | 0.040 |
Why?
|
Response Elements | 1 | 2018 | 312 | 0.040 |
Why?
|
Neoplasms | 3 | 2016 | 21683 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 655 | 0.030 |
Why?
|
Carbazoles | 1 | 2017 | 226 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2017 | 853 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3505 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 11124 | 0.030 |
Why?
|
Rodentia | 1 | 2016 | 261 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2866 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12797 | 0.030 |
Why?
|
Transgenes | 1 | 2017 | 1009 | 0.030 |
Why?
|
Chromones | 1 | 2013 | 154 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5974 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2013 | 156 | 0.030 |
Why?
|
Dioxoles | 1 | 2013 | 104 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 163 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2014 | 195 | 0.030 |
Why?
|
Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3768 | 0.030 |
Why?
|
Up-Regulation | 2 | 2012 | 4217 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1276 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 698 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 314 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1420 | 0.030 |
Why?
|
Luciferases | 1 | 2014 | 733 | 0.030 |
Why?
|
Schwann Cells | 1 | 2012 | 195 | 0.020 |
Why?
|
Dipeptides | 1 | 2013 | 409 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9727 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1951 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 730 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1950 | 0.020 |
Why?
|
Larva | 1 | 2012 | 519 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2016 | 847 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1172 | 0.020 |
Why?
|
Morpholines | 1 | 2013 | 571 | 0.020 |
Why?
|
Stem Cells | 2 | 2014 | 3567 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13102 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3616 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 907 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2012 | 517 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2012 | 652 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1379 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 720 | 0.020 |
Why?
|
Phylogeny | 2 | 2006 | 2803 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
Endoderm | 1 | 2008 | 154 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2012 | 13815 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1252 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 1060 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 18111 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5179 | 0.020 |
Why?
|
Mutation | 3 | 2017 | 29786 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 944 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6386 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4204 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2014 | 2072 | 0.020 |
Why?
|
Mesoderm | 1 | 2008 | 686 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2088 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2421 | 0.020 |
Why?
|
Receptors, Interleukin-18 | 1 | 2004 | 22 | 0.020 |
Why?
|
Morphogenesis | 1 | 2008 | 752 | 0.020 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2004 | 18 | 0.020 |
Why?
|
Toll-Like Receptor 1 | 1 | 2004 | 48 | 0.010 |
Why?
|
Toll-Like Receptor 5 | 1 | 2004 | 39 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1058 | 0.010 |
Why?
|
Sequence Homology | 1 | 2004 | 203 | 0.010 |
Why?
|
Toll-Like Receptor 3 | 1 | 2004 | 91 | 0.010 |
Why?
|
Toll-Like Receptor 8 | 1 | 2004 | 90 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 35421 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1713 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3798 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2004 | 258 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2004 | 245 | 0.010 |
Why?
|
Toll-Like Receptor 7 | 1 | 2004 | 172 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3386 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2008 | 879 | 0.010 |
Why?
|
Motor Activity | 1 | 2012 | 2714 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2839 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2004 | 354 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9583 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4320 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 592 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2256 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7186 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14557 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11483 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15997 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3846 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41006 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4803 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6773 | 0.010 |
Why?
|
Female | 3 | 2018 | 380194 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63114 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
Child | 1 | 2017 | 77709 | 0.010 |
Why?
|
Male | 2 | 2014 | 350118 | 0.000 |
Why?
|